Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

Scientific Publications

Therapixel-launched-new-website-Therapixel

September 24, 2020

Scientific Publications

Performances of using Mammoscreen™️ have been demonstrated…

Text

Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy May 14, 2022
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D May 12, 2022
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis November 28, 2021

RECOMMENDED POSTS

Therapixel secures a €5 million Series A financing and strengthens its governance
Therapixel receives FDA 510(k) clearance for MammoScreen™
Therapixel is now ISO/IEC 27001 certified
Therapixel participates in the Journées Francophones de Radiologie 2020
Scientific Publications

© 2020 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences